Mallinckrodt Pharmaceuticals To Hold Investor Briefing October 14, 2014, In New York

DUBLIN--(BUSINESS WIRE)--Mallinckrodt plc. (NYSE: MNK), a leading global specialty pharmaceutical company, will hold an investor briefing on Tuesday, October 14, 2014, in New York City. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will present along with members of Mallinckrodt’s senior management team. The presentation will include announcement of the company’s fiscal year 2015 financial guidance.

Help employers find you! Check out all the jobs and post your resume.